Arbutus Biopharma
ABUS
#6232
Rank
HK$6.67 B
Marketcap
HK$34.70
Share price
-1.33%
Change (1 day)
21.31%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): -HK$2.57

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is -HK$2.57. In 2024 the company made an earnings per share (EPS) of -HK$2.96 an increase over its 2023 EPS that were of -HK$3.42.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.57-13.11%
2024-HK$2.96-13.64%
2023-HK$3.42-4.35%
2022-HK$3.58-44.58%
2021-HK$6.46-17%
2020-HK$7.78-65.4%
2019-HK$22.49138.84%
2018-HK$9.42-22.44%
2017-HK$12.14-78.45%
2016-HK$56.34424.64%
2015-HK$10.74-20.19%
2014-HK$13.4687.96%
2013-HK$7.16-142.59%
2012HK$16.81-342.7%
2011-HK$6.93-25.82%
2010-HK$9.3447.8%
2009-HK$6.32-43.55%
2008-HK$11.19158.91%
2007-HK$4.32-111.88%
2006HK$36.38-552.53%
2005-HK$8.04-71.77%
2004-HK$28.48-14.48%
2003-HK$33.30-8.95%
2002-HK$36.5870.07%
2001-HK$21.5148.01%
2000-HK$14.53-38.54%
1999-HK$23.64-24.6%
1998-HK$31.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
NRC Health
NRC
HK$5.45-312.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-HK$0.47-81.82% Bahamas